SBEC Systems Q1 FY27 results: revenue and profit decline YoY

Revenue DeclineEbitda Margin CompressionResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.4%Reaction day

₹20.50

prior close

₹20.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-4.6% vs market

Trading & Distributors peers, median of 125sector+0.0%-4.4% vs sector

On the reaction day the stock moved 4.6 pts less than Nifty Microcap 250 and 4.4 pts less than its Trading & Distributors peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.3

10m

-2.3

15m

-2.3

30m

-2.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.4+0.1-4.6+0.0-4.4

Next day

-3.5+0.5-4.0-0.4-3.1

-11.5-0.1-11.4-1.0-10.5

-4.9+0.4-5.3-0.4-4.5

-1.2+0.7-1.9+0.0-1.2

-2.7+0.9-3.6-1.1-1.5

-1.8+1.1-2.9-1.5-0.3

15d

+1.0+1.6-0.6-2.1+3.2

-2.4-0.7-1.7-3.2+0.8

-8.3-3.2-5.0-5.7-2.6

—————

UpDownMarket · Nifty Microcap 250Sector · Trading & Distributors peers, median of 125Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

SBEC Systems posted Q1 FY27 consolidated revenue of Rs 86.16 lakhs versus Rs 106.10 lakhs YoY, an about 19 percent decline. Technical services revenue fell to Rs 46.19 lakhs from Rs 76.41 lakhs. PBT dropped to Rs 19.29 lakhs from Rs 38.99 lakhs. PAT was Rs 19.29 lakhs vs Rs 177.42 lakhs, with prior year boosted by a Rs 138.43 lakh deferred tax credit. EPS stood at Rs 0.19. Auditor issued clean limited review. Capital reduction scheme pending at NCLT.

Likely market impact

Revenue and core profitability both declined YoY. Capital reduction scheme awaiting NCLT approval remains a key overhang for shareholders.